Neuropace Inc (NPCE) financials
Neuropace revenue and earnings by year
Neuropace's revenue was $100.0 million in the fiscal year to December 31, 2025, up 25.1% from the year before. Net income was -$21.5 million, -21.5% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 18.0% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 7 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 100 | 80 | 65 | 46 | 45 | 41 | 37 |
| Revenue growth | 25.1% | 22.1% | 43.7% | 0.7% | 9.8% | 11.3% | — |
| Gross profit | 77 | 59 | 48 | 32 | 33 | 30 | 26 |
| Gross margin | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% | 73.6% | 71.6% |
| Operating income | -16 | -22 | -27 | -41 | -24 | -13 | -22 |
| Operating margin | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% | -31.7% | -59.6% |
| Net income | -21 | -27 | -33 | -47 | -36 | -24 | -30 |
| Net margin | -21.5% | -34.0% | -50.4% | -103.4% | -79.9% | -59.0% | -81.1% |
| Diluted EPS | -$0.66 | -$0.93 | -$1.27 | -$1.91 | -$2.17 | -$117.85 | — |
| Free cash flow | -11 | -18 | -20 | -37 | -25 | -22 | -25 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open NPCE in Markets.
See also: NPCE returns
No forecast, no recommendation. This page describes Neuropace Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.